Scand J Infect Dis. 1992;24(2):215-8.

A comparison of aztreonam and ceftazidime in the treatment of respiratory infections in adults with cystic fibrosis.

Salh B, Bilton D, Dodd M, Abbot J, Webb K.

Source

Adult Regional Cystic Fibrosis Unit, Monsall Hospital, Manchester, U.K.

Abstract

A randomised double blind 2-week trial of monotherapy with ceftazidime and aztreonam was completed in 22 adults with cystic fibrosis. 26 courses of treatment were initiated and 22 courses were completed. Within groups, both ceftazidime and aztreonam demonstrated a significant improvement in FEV1 at 2 weeks (ceftazidime p less than 0.05; aztreonam p less than 0.01) and a decline in sputum weight at 2 weeks (ceftazidime p less than 0.05; aztreonam p less than 0.05). Between groups, for spirometry and sputum weight the only change was a slower decline in FEV1 in the aztreonam group at 42 days (p less than 0.05).

PMID:: 1641599; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Treatment of lower respiratory tract infections due to Pseudomonas aeruginosa in patients with cystic fibrosis. [Rev Infect Dis. 1985]
Treatment of lower respiratory tract infections due to Pseudomonas aeruginosa in patients with cystic fibrosis.
Scully BE, Ores CN, Prince AS, Neu HC. Rev Infect Dis. 1985 Nov-Dec; 7 Suppl 4:S669-74.
The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in patients with cystic fibrosis. [Chest. 2005]
The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in patients with cystic fibrosis.
Blumer JL, Saiman L, Konstan MW, Melnick D. Chest. 2005 Oct; 128(4):2336-46.
Efficacy of once-daily tobramycin monotherapy for acute pulmonary exacerbations of cystic fibrosis: a preliminary study. [Pediatr Pulmonol. 2001]
Efficacy of once-daily tobramycin monotherapy for acute pulmonary exacerbations of cystic fibrosis: a preliminary study.
Master V, Roberts GW, Coulthard KP, Baghurst PA, Martin A, Roberts ME, Onishko CR, Martin AJ, Linke RJ, Holmes M, et al. Pediatr Pulmonol. 2001 May; 31(5):367-76.
Review Leukotriene receptor antagonists in children with cystic fibrosis lung disease : anti-inflammatory and clinical effects. [Paediatr Drugs. 2005]
Review Leukotriene receptor antagonists in children with cystic fibrosis lung disease : anti-inflammatory and clinical effects.
Schmitt-Grohé S, Zielen S. Paediatr Drugs. 2005; 7(6):353-63.
Review Aztreonam: review of the clinical experience and potential uses in pediatrics. [Pediatr Infect Dis J. 1988]
Review Aztreonam: review of the clinical experience and potential uses in pediatrics.
Lebel MH, McCracken GH Jr. Pediatr Infect Dis J. 1988 May; 7(5):331-9.

See reviews... See all...

Cited by 1 PubMed Central article

Pharmacokinetics of aztreonam in healthy subjects and patients with cystic fibrosis and evaluation of dose-exposure relationships using monte carlo simulation. [Antimicrob Agents Chemother. 2...]
Pharmacokinetics of aztreonam in healthy subjects and patients with cystic fibrosis and evaluation of dose-exposure relationships using monte carlo simulation.
Vinks AA, van Rossem RN, Mathôt RA, Heijerman HG, Mouton JW. Antimicrob Agents Chemother. 2007 Sep; 51(9):3049-55. Epub 2007 Jun 18.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Search details

Recent activity

Clear Turn Off Turn On

A comparison of aztreonam and ceftazidime in the treatment of respiratory infect...
A comparison of aztreonam and ceftazidime in the treatment of respiratory infections in adults with cystic fibrosis.
Scand J Infect Dis. 1992 ;24(2):215-8.

PubMed
1641599[uid] (1)
PubMed
Community lay rescuer automated external defibrillation programs: key state legi...
Community lay rescuer automated external defibrillation programs: key state legislative components and implementation strategies: a summary of a decade of experience for healthcare providers, policymakers, legislators, employers, and community leaders from the American Heart Association Emergency Cardiovascular Care Committee, Council on Clinical Cardiology, and Office of State Advocacy.
Circulation. 2006 Mar 7 ;113(9):1260-70. Epub 2006 Jan 16 .

PubMed
Cystic fibrosis: terminology and diagnostic algorithms.
Cystic fibrosis: terminology and diagnostic algorithms.
Thorax. 2006 Jul ;61(7):627-35. Epub 2005 Dec 29 .

PubMed
16384879[uid] (1)
PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

A comparison of aztreonam and ceftazidime in the treatment of respiratory infections in adults with cystic fibrosis.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 1 PubMed Central article

Related information

Search details

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information